Track topics on Twitter Track topics that are important to you
Medical devices are crucial to the process of diagnosis and treatment in modern medicine. Sales in this field reach billions of dollar a year, with Johnson & Johnson making $30 billion alone in ...
A regulatory report by device manufacturer Olympus Corp. found that hospitals have continued to use the medical device that was recalled in January. Meanwhile, a lawsuit is filed against another compa...
Body: An analysis from ProPublica found doctors who received money from pharmaceutical companies and medical device manufacturers prescribed a higher percentage of branded medications compared wi...
Corvia Medical has received CE mark approval for its InterAtrial shunt device (IASD) to treat heart failure with preserved ejection fraction (HFpEF) or diastolic heart failure.
A Grand View Research report predicts the US medical device outsourcing market will hit $27.8 billion by 2022. -More-
(MedPage Today) -- Heart failure device can be cost-effective for certain subgroups, analysis says
Blood-contacting implantable medical devices, such as stents, heart valves, ventricular assist devices, and extracorporeal support systems, as well as vascular grafts and access catheters, are used wo...
The newly established planning board is made up of experts representing patients, clinicians, academic researchers, the medical device industry and others, and is supported in its work by the Duke-Mar...
TEWKSBURY, Mass., May 12, 2016 /PRNewswire/ -- Corvia Medical, Inc., a privately-held medical device company that has developed a first-in-class structural heart device to treat heart failure, to...
Medical devices are manifold and one of the most innovative fields of technology. As technologies advance, former limits cease to exist and complex devices become reality. Medical devices represent a ...
Despite significant advances in optimizing drug therapy, heart failure-related mortality and morbidity remain high. There has been great progression with regard to device therapy in heart failure, and...
The development of ventricular assist device (VAD) has been one of the revolutionary advancements in end-stage heart failure management. Although the device has developed and improved significantly ov...
This study aimed to evaluate the cost-effectiveness of the CardioMEMS (CardioMEMS Heart Failure System, St Jude Medical Inc, Atlanta, Georgia) device in patients with chronic heart failure.
We report a new, noninvasive Zip surgical skin closure device (ZipLine Medical, Campbell, CA). This device is considered to have good cosmetic outcomes after operations and reduces surgical time. In t...